Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology,General Medicine
Reference17 articles.
1. Bevacizumab for the first-line treatment of human epidermal growth factor receptor 2-negative advanced breast cancer;Damasceno;Curr Opin Oncol,2011
2. Topographic Pathology of Cancer;El-Bolkiany,2008
3. Management of breast cancer with targeted agents: importance of heterogeneity [corrected];Di Cosimo;Nat Rev Clin Oncol,2010
4. Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up;Rydén;Breast Cancer Res Treat,2010
5. Triple-negative breast cancer: role of specific chemotherapy agents;Isakoff;Cancer J,2010
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trial;The Breast;2023-12
2. Implementation of pharmaceutical care service to elderly cancer patients in a tertiary care hospital in South India;Journal of Oncology Pharmacy Practice;2022-12-12
3. A Review on Nanocarrier Mediated Treatment and Management of Triple Negative Breast Cancer: A Saudi Arabian Scenario;Frontiers in Oncology;2022-07-22
4. Efficacy of Sequential Capecitabine on Adjuvant Chemotherapy of Triple-Negative Breast Cancer;Journal of Healthcare Engineering;2022-02-28
5. Toxicity profile, adverse drug reactions and drug-drug interactions among geriatric cancer patients under metronomic chemotherapy in a South Indian tertiary care hospital;Journal of Oncology Pharmacy Practice;2022-02-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3